Clorox CLX has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 0 | 4 | 3 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 3 | 3 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $155.29, a high estimate of $174.00, and a low estimate of $137.00. Observing a 6.78% increase, the current average has risen from the previous average price target of $145.43.
Exploring Analyst Ratings: An In-Depth Overview
The analysis of recent analyst actions sheds light on the perception of Clorox by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Chris Carey | Wells Fargo | Raises | Equal-Weight | $157.00 | $155.00 |
Robert Moskow | TD Cowen | Raises | Hold | $170.00 | $155.00 |
Linda Bolton Weiser | DA Davidson | Raises | Neutral | $171.00 | $153.00 |
Lauren Lieberman | Barclays | Raises | Underweight | $139.00 | $137.00 |
Javier Escalante | Evercore ISI Group | Lowers | Underperform | $139.00 | $140.00 |
Lauren Lieberman | Barclays | Raises | Underweight | $137.00 | $130.00 |
Andrea Teixeira | JP Morgan | Raises | Neutral | $174.00 | $148.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Clorox. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Clorox compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Clorox's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Clorox's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Clorox analyst ratings.
Get to Know Clorox Better
Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.
Financial Insights: Clorox
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Clorox's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 27.13%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Clorox's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 5.62%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Clorox's ROE excels beyond industry benchmarks, reaching 51.03%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Clorox's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.76%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Clorox's debt-to-equity ratio stands notably higher than the industry average, reaching 48.07. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
The Basics of Analyst Ratings
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.